Brief: Immutep Says Granted United States Patent For IMP761
20/06/2023 09:28
June 20 (Reuters) - Immutep Ltd IMM.AX :
* GRANTED UNITED STATES PATENT FOR IMP761, A FIRST-IN-CLASS
AGONIST ANTIBODY TARGETING LAG-3
Source text for Eikon: ID:nASX9VRFwQ
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))